Uniplan Investment Counsel’s cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock YCBD.PRA Stock Holding History

Uniplan Investment Counsel’s Portfolio YCBD.PRA Stock Details YCBD.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-323,070	Closed	-$2.26M	–	141
2021 Q3	$2.26M	Sell	323,070 -12,949	-4%	-$92.2K	0.14%	118
2021 Q2	$2.51M	Buy	336,019 +70,654	+27%	+$620K	0.15%	117
2021 Q1	$2.4M	Sell	265,365 -8,459	-3%	-$73.2K	0.15%	107
2020 Q4	$2.12M	Buy	+273,824	New	+$2.21M	0.15%	108

Other funds holding YCBD.PRA

CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return

WAM

Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Intellectus Partners San Francisco, California $490M AUM 35.11% 1-Year Est. Return

KJHP

K.J. Harrison & Partners Toronto, Ontario, Canada $608M AUM 45.31% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GWMIA

Global Wealth Management Investment Advisory Fort Lauderdale, Florida $703M AUM 20.48% 1-Year Est. Return

Uniplan Investment Counsel's YCBD.PRA Position: Q4 2021 in Review

Uniplan Investment Counsel sold out of cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock (YCBD.PRA) in Q4 2021, closing a stake of 323,070 shares — an estimated $2.26M sold.

Uniplan Investment Counsel first reported a position in YCBD.PRA in Q4 2020 and held it in 4 quarters. The position peaked at $2.51M in Q2 2021. 9 funds tracked by Wall St. Rank hold YCBD.PRA as of Q4 2021.

Uniplan Investment Counsel reported no remaining cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock position as of Q4 2021 after selling out during the quarter.
Uniplan Investment Counsel sold 323,070 cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock shares in Q4 2021, an estimated $2.26M.
Uniplan Investment Counsel first reported a position in cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock in Q4 2020 and held it in 4 quarters.
Uniplan Investment Counsel's cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock position peaked at $2.51M in Q2 2021.
9 funds tracked by Wall St. Rank held cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock as of Q4 2021.

Based on Uniplan Investment Counsel's 13F filing for Q4 2021, filed 14 Feb 2022.